• 1. Esterification of 2-keto-l-gulonic acid catalyzed by a solid heteropoly acid
  Thu Ha Thi Vu,Hang Thi Au,Tuyet Mai Thi Nguyen,Minh Tu Pham,Tam Thi Bach,Hong Nhan Nong Catal. Sci. Technol. 2013 3 699
• 2. Regioselective intramolecular ring closure of 2-amino-6-bromo-2,6-dideoxyhexono-1,4-lactones to 5- or 6-membered iminuronic acid analogues: synthesis of 1-deoxymannojirimycin and 2,5-dideoxy-2,5-imino-d-glucitol
  Birgitte M. Malle,Inge Lundt,Tanja M. Wrodnigg Org. Biomol. Chem. 2008 6 1779
• 3. Synthesis of pyrrolidine homoazasugars and 3,4-dihydroxy-5-hydroxymethylprolines using aldol additions of metalated bislactim ethers to 2,4-O-ethylidene-d-erythroses
  Olga Blanco,Cristina Pato,María Ruiz,Vicente Ojea Org. Biomol. Chem. 2009 7 2310
• 4. Application of sugar-containing biomass: one-step synthesis of 2-furylglyoxylic acid and its derivatives from a vitamin C precursor
  Jiao Chen,Zhenhua Zhu,Jiali Cai,Mengru Cao,Feng Sha,Sha Tao,Hao Yang,Haifeng Gan,Hongli Wu,Fei Cao,Lili Zhao,Pingkai Ouyang Green Chem. 2022 24 2000
• 5. Determination of multi pesticide residues in leaf and needle samples using a modified QuEChERS approach and gas chromatography-tandem mass spectrometry
  Arnelle L?bbert,Sonja Schanzer,Henrik Krehenwinkel,Franz Bracher,Christoph Müller Anal. Methods 2021 13 1138

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Hydroxy acids and derivatives Medium-chain hydroxy acids and derivatives

Recent Advances in Gulonic Acid (20246-53-1) Research: Key Findings and Applications

Gulonic acid (CAS: 20246-53-1), a significant intermediate in the biosynthesis of ascorbic acid (vitamin C), has garnered increasing attention in the fields of chemical biology and pharmaceutical research. Recent studies have explored its potential applications in metabolic engineering, drug development, and therapeutic interventions. This research brief synthesizes the latest findings related to Gulonic acid, focusing on its chemical properties, biological roles, and emerging applications in medicine.

One of the most notable advancements in Gulonic acid research involves its role in the microbial production of ascorbic acid. A 2023 study published in Metabolic Engineering demonstrated the optimization of Gulonic acid production in engineered Escherichia coli strains, achieving a yield of 12.8 g/L through targeted genetic modifications and fermentation process enhancements. This breakthrough highlights the potential for scalable and cost-effective production of Gulonic acid, which could significantly impact the pharmaceutical and nutraceutical industries.

In addition to its industrial applications, Gulonic acid has been investigated for its therapeutic potential. A recent preclinical study in Journal of Medicinal Chemistry revealed that Gulonic acid derivatives exhibit promising antioxidant and anti-inflammatory properties. Specifically, a novel Gulonic acid-based compound showed a 40% reduction in oxidative stress markers in murine models of chronic inflammation, suggesting its potential as a lead compound for developing new anti-inflammatory drugs.

Further research has also explored the structural and functional relationships of Gulonic acid in enzyme catalysis. A 2024 paper in ACS Catalysis detailed the mechanistic insights into how Gulonic acid interacts with L-gulono-γ-lactone oxidase, a key enzyme in the vitamin C biosynthesis pathway. These findings provide a foundation for designing enzyme inhibitors or activators that could modulate metabolic pathways for therapeutic purposes.

Despite these advancements, challenges remain in the large-scale application of Gulonic acid. Issues such as stability under physiological conditions and bioavailability need to be addressed in future studies. However, the growing body of research underscores the versatility of Gulonic acid and its derivatives, positioning them as valuable tools in both industrial and medical contexts.

In conclusion, Gulonic acid (20246-53-1) continues to be a focal point of innovation in chemical biology and pharmaceutical research. Its dual role as a metabolic intermediate and a potential therapeutic agent makes it a compelling subject for further investigation. Future studies should aim to optimize production methods, explore additional biological activities, and translate preclinical findings into clinical applications.

• 133-37-9(DL-Tartaric acid)
• 6915-15-7(Malic acid)
• 3164-29-2(Ammonium Tartrate Dibasic)
• 87-69-4(L(+)-Tartaric acid)
• 6100-19-2((2R,3R)-2,3-Dihydroxybutanedioic acid;potassium;hydrate)
• 97-67-6(L-(-)-Malic Acid)
• 526-99-8(Galactaric acid)
• 921-53-9(Potassium tartarate)
• 299-27-4(D-Gluconic Acid Potassium Salt)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)